Vertex Pharmaceutica
VRTX
Delayed Nasdaq - 02/16 10:00:00 pm
160.72USD
-0.14%
Upcoming events

- No events available -

Past Events
01/31/18 | 10:30pmFY 2017 Earnings Call
01/31/18FY 2017 Earnings Release
01/08/18 | 06:30pmJ.P. Morgan Health Care Conference
12/10/17American Society of Hematology Meeting
Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
2 174
2 332
-6,8%

2 765
Operating income (EBITDA)
Million $
Released
Forecast
Spread

562

909
Operating profit (EBIT)
Million $
Released
Forecast
Spread
550
536
2,5%

828
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
263
293
-10%

482
EPS
 $
Released
Forecast
Spread
1,04
1,02
1,7%

1,86
Announcement Date01/31/2018
Quarterly / Semiannualy publications
Quarterly resultsQ4
2017
Q1
2018 (e)
Sales
Million $
Released
Forecast
Spread
623
596
4,5%

618
Operating income (EBITDA)
Million $
Released
Forecast
Spread

105

191
Operating profit (EBIT)
Million $
Released
Forecast
Spread
183
148
24%

159
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
101
78,8
28%

105
EPS
 $
Released
Forecast
Spread
0,39
0,31
26%

0,38
Announcement Date01/31/2018
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise